ENTA Enanta Pharmaceuticals Inc.

$79.485 +0.18%

132,172 Shares Traded
252,226 Average Volume (last 30 days)

as of February 22, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Lost on the Day: $154.05 thousand
If Intiated on the First, Shorts Have Realized a Year to Date Return of:-36.86%
If Intiated One Month Ago, Shorts Have Realized a Return of:-12.2%
If Initiated Five Days ago, Shorts Have Realized a Return of:0.43%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bullish
50 Day Moving Average Indicator Bullish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 5.87%
Short Interest1.06 million
Float18.09 million
Short Ratio5.93
Market Cap$1.52 billion
Market Maker ActivityDaily Short Volume

News

02-12-2018
Enanta Pharmaceuticals to Present at Two Upcoming Investor Conferences (Business Wire)
02-09-2018
Your Daily Pharma Scoop: Adamas' Gocovri Key Value Driver, BioMarin Data, Regeneron Q4 Results (SeekingAlpha)
02-07-2018
Enanta Pharmaceuticals' (ENTA) CEO Jay Luly on Q1 2018 Results - Earnings Call Transcript (SeekingAlpha)
02-07-2018
Enanta Pharma beats by $0.32, beats on revenue (SeekingAlpha)
02-07-2018
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2017 (Business Wire)
01-29-2018
Enanta Pharma continues northward march, up 6% (SeekingAlpha)
01-24-2018
Enanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss Financial Results for its Fiscal First Quarter Ended December 31, 2017 (Business Wire)
01-11-2018
Enanta Pharma (ENTA) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slideshow (SeekingAlpha)
01-05-2018
Enanta Pharma to provide R&D updates programs and 2018 outlook at 36th Annual J.P. Morgan Healthcare Conference (SeekingAlpha)
01-05-2018
Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and Business Outlook for 2018 during the 36th Annual J.P. Morgan Healthcare Conference (Business Wire)


Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 62.3%

Earnings Stats

PE Ratio 90.24
Dividend Yield 0%
Peer EarningsEarnings Calendar

Technicals

200 Day Moving Average $47.5
50 Day Moving Average $67.83
52 Week High $95.91
52 Week Low $27.24



Data provided for free by IEX. Questions? Read the FAQ